Proathlete Wealth Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Proathlete Wealth Management’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	12	–	–	﹤0.01%	311
2026 Q1	$0	Hold	12	–	–	﹤0.01%	316
2025 Q4	$0	Hold	12	–	–	﹤0.01%	322
2025 Q3	$0	Hold	12	–	–	﹤0.01%	330
2025 Q2	$0	Hold	12	–	–	﹤0.01%	329
2025 Q1	$0	Buy	+12	New	–	﹤0.01%	208

Proathlete Wealth Management's EFTR Position: Q2 2026 in Review

Proathlete Wealth Management held its eFFECTOR Therapeutics, Inc. Common Stock (EFTR) position steady in Q2 2026 at 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #311.

Proathlete Wealth Management first reported a position in EFTR in Q1 2025 and has held it in 6 quarters since. 1 fund tracked by Wall St. Rank holds EFTR as of Q2 2026.

Proathlete Wealth Management held 12 shares of eFFECTOR Therapeutics, Inc. Common Stock worth $0 as of Q2 2026.
Proathlete Wealth Management left its eFFECTOR Therapeutics, Inc. Common Stock share count unchanged in Q2 2026.
eFFECTOR Therapeutics, Inc. Common Stock made up ﹤0.01% of Proathlete Wealth Management's portfolio in Q2 2026, its #311 holding.
Proathlete Wealth Management first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q1 2025 and has held it in 6 quarters since.
1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.